Updated 08:06 GMT, 4 Nov 2026 SPX 7,568.92 +0.36% NDX 28,180.26 +0.68% VIX 20.83 -1.51% GOLD 4,030.50 +2.29% CL 96.12 +0.03% BTC 78,242.15 +1.16%
NAS100 28,180 +0.68% S&P 7,569 +0.36% GOLD $4,031 +2.29% BTC $78,242 +1.16% VIX 20.83 −1.51% latest tape · as of 08:06 UTC
The Screen · Energy · Oil & Gas Midstream

Pyxis Tankers Inc

PXS · NASDAQ · USD · Market cap $44M

Pyxis Tankers Inc.

FAIL · Does not pass the screen
6.53 USD

Price as of 3 Nov 2026Daily close, not a live quote

Screened 2026-11-03 · the tape above runs as of 08:06 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price6.53 USD at the 3 Nov 2026 close
  • Fair valueUnder review: only one analyst covers it, too few to cross-check it; our model's value is 1.54x the price, above our 1.35x limit.
  • Our regime readDistribution, as of 3 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed3 Nov 2026 (1 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-03).

Current read
Distribution ?
Screened · screened 2026-11-03
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price6.53 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Distribution7.11-8.2% to today ✓Markup gives way to Distribution after a 64% rise in 7 weeks
2026-09-10Read Markup4.34+50.3% to today ✓Accumulation gives way to Markup
2026-08-09Read Accumulation4.34+50.3% to today ✓Distribution gives way to Accumulation after a 6% slide in 5 weeks
2026-07-02Read Distribution4.62+41.2% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Pyxis Tankers Inc holds its Distribution at $6.53. Consolidating, no directional conviction, held for 22 days.

As held on the ledger · 2026-11-03
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 22 days
Price at the screen$6.53
Valuation21.03 trailing · 5.04 forward price to earnings
Values screenFAIL · score 70.0
Beta-0.52
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 45.11% Below 33% Interest-bearing debt is 45.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 9.31% Below 33% Cash held in interest-bearing accounts and securities is 9.3% of assets, under the one-third limit. Pass
Receivables 19.42% Below 49% Money owed to the company is 19.4% of assets, under the 49% limit. Pass
Revenue purity 4.60% Below 5% Only 4.6% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Pyxis Tankers's business is in a permissible area, but its interest-bearing debt is about 45% of the company, well over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PXS's ethical verdict changes

Today PXS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Fair value under review. Only one analyst covers it, too few to cross-check it; our model's value is 1.54x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.

How a fair value is estimated: discounted cash flow (DCF).

Price History & Projections

Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-03 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E5.0xpriced for continued growth
Trailing P/E21.0xa premium valuation
EPS, trailing0.35
EPS, forward1.46
Revenue growth+3.9%slow but positive growth
Profit margin9.3%thin but positive margins
Return on equity3.9%a modest return on shareholder capital
FCF yield23.80%
Debt to equity0.82moderate, manageable leverage
Current ratio4.53comfortably covers its short-term bills
Beta-0.52barely tracks the market's swings
Short interest, float0.01%
52-week range2.47 - 4.92
MoatNONE
Market cap$44M

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Greece and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PXS trades on NASDAQ (the company is based in Greece). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-01 Distribution · changed $7.11 -13.1% Entry 8

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 13.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-10-21 Markup $8.18 +11.1% Entry 7

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 77% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-10-02 Markup $7.36 +69.6% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 69.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 39% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-09-10 Markup · changed $4.34 +0.0% Entry 5

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 39% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-08-09 Accumulation · changed $4.34 -6.1% Entry 4

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 39% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-07-18 Distribution $4.62 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 39% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 69%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (1 analysts) rates it none, with a mean price target of $10.

2026-07-03 Distribution $4.62 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Distribution $4.62 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in PXS's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $4.48 +4.0% · $1,040 +4.0%
2 months $4.45 +4.7% · $1,047 +4.7%
3 months $3.88 +20.1% · $1,201 +20.1%
6 months $3.02 +54.6% · $1,546 +54.6%
1 year $2.76 +69.2% · $1,692 +69.2%
2 years $5.18 -10.0% · $900 -10.0%
3 years $3.72 +25.3% · $1,253 +25.3%
5 years $3.71 +25.7% · $1,257 +25.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PXS does next, these words stay.

Pyxis Tankers Inc · PXS · Distribution · $6.53
Recorded 2026-11-03 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.